Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiaoyao Pill for Depression in Parkinson's Disease
NCT01416818Phase 2Unknown
- Sponsor
- Xuanwu Hospital
- Start
- May 2008
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of xiao yao san in major depressive disorder (MDD), sponsored by Xuanwu Hospital. Primary endpoint: Hamilton Depression Scale at 12 weeks. Status: unknown.
02
Drugs
xiao yao san
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01416818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01416818.